MedPath

Advanced Breast Cancer and Lifestyle Exercise Study

Not Applicable
Completed
Conditions
Metastatic Breastcancer
Interventions
Other: PA intervention
Registration Number
NCT03148886
Lead Sponsor
Centre Leon Berard
Brief Summary

About 5% of breast cancers are metastatic at diagnosis and 20-30% of localized breast cancer become secondarily metastatic.Thanks to recent therapeutic advances, the median survival ranges between 12 months in 1970 and 18 to 24 months in 2000. However, patients suffer from many detrimental symptoms such as fatigue, pain related to treatment and metastasis. The physical, biological, psychological and clinical benefits of physical activity (PA) during treatment in patients with localized breast cancer have been widely demonstrated. Numerous studies investigated the effect of PA in non-metastatic breast cancer, but to our knowledge, only four interventional studies worldwide focused on the implementation of PA in patients with metastatic breast cancer.It seems appropriate to investigate the feasibility of PA intervention with patients with metastatic breast cancer to see if the observed effects in localized breast cancer are confirmed in metastatic breast cancer population. The ABLE study is an interventional cohort designed to assess the feasibility of a 6-month adapted physical activity intervention, performed under real life conditions in patients with metastatic breast cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
51
Inclusion Criteria
  • aged 18 to 78 years old,
  • newly diagnosed with a metastatic breast cancer (i.e. within the last 3 months)
  • treated in the CLB by chemotherapy, and/or radiotherapy and/or hormonotherapy and/or targeted therapy.
  • ECOG Performance status <2,
  • being French-speaking
  • able to complete questionnaires and follow instructions in French
  • valid health insurance affiliation.
  • medical certificate of no contraindications to exercise physical activity
Exclusion Criteria
  • untreated brain metastases
  • uncontrolled cardiac disease,
  • contraindications to PA,
  • unable to be followed for medical, social, familial, geographical or psychological reasons over the study duration,
  • deprivation of liberty by court or administrative decision
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PA interventionPA interventionThe intervention consisted in a home-based adapted PA program defined at the inclusion, according to patient's capacities.
Primary Outcome Measures
NameTimeMethod
Proportion of patients achieving the physical activity program recommendations6 months

150 min per week of moderate PA assessed by the IPAQ

Secondary Outcome Measures
NameTimeMethod
Investigate the effects of a PA intervention on fatigue6 months

PIPER scale

Investigate the effects of a PA intervention on changes in anthropometrics6 months

Hip circumference in centimeters

Variation of oxidative stress6 months

7mL blood sample is collected at baseline and at the end of the study

Investigate the effects of a PA intervention on fitness level6 months

strength test in kilograms

Investigate the effects of a PA intervention on quality of life6 months

BR-23

Investigate the effects of a PA intervention on social deprivation6 months

EPICES score

Investigate the barriers and facilitators of adherence to a PA program6 months

Specific questionnaire

Trial Locations

Locations (1)

Centre Léon Bérard

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath